User banner image
User avatar
  • admin

Posts

Ollie’s Bargain Outlet Holdings, Inc. Announces Second Quarter Fiscal 2024 Release Date and Conference Call Information

HARRISBURG, Pa., Aug. 15, 2024 (GLOBE NEWSWIRE) — Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) announced today that it will release its financial...

Media Advisory: Memorial Ceremony Held for Manitoba Victims of Impaired Driving

WEST ST. PAUL, Manitoba, Aug. 15, 2024 (GLOBE NEWSWIRE) — Families and friends of individuals who were killed and those who suffered serious injuries as...

Zero Turn Mower Market to exceed $4.18 Bn by 2032, Says Global Market Insights Inc.

Major zero turn mower market participants include Ariens, MTD Products Inc, Bad Boy Mowers, Briggs & Stratton Corporatio, Cub Cadet, Dixie Chopper, Exmark, Ferris Industries,...

Shenzhen’s Futian Encourages Public Attention and Engagement in Urban Wildlife Conservation

SHENZHEN, China, Aug. 15, 2024 (GLOBE NEWSWIRE) — A gigantic yet gentle Bryde’s whale encounters a massive ship in coastal waters; Chinese pond herons and common...

IDEX Biometrics interim report for the first half of 2024

Oslo, Norway – 15 August 2024 – IDEX Biometrics ASA’s interim report for the first half of 2024 is attached to this notice (link below)....

Pathos Expands Pipeline With Worldwide License of Phase 2-ready Brain-penetrant, PRMT5 Inhibitor

CHICAGO, Aug. 15, 2024 (GLOBE NEWSWIRE) — Pathos AI, Inc. (www.pathos.com), a biotechnology company focused on revolutionizing precision medicine in cancer by harnessing the power...

DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function

TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) — DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain...

Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular Carcinoma

Broad agreement on pivotal Phase 3 study plan, including use of current amezalpat dose and schedule Overall survival, the strongest result from the Phase 2...

Empower: Discover the Future of Healthcare at Inovalon’s Annual Data-Driven Summit

Hear from Former CDC Director and Visionary Executives from AWS, Oracle Cloud Infrastructure, Snowflake, and Many Other Organizations on the Forefront of Data-Driven Healthcare BOWIE,...

Noah Medical Shares Diagnostic Confidence of its Galaxy Users at AABIP 2024

Next-generation robotics company to share field results, deliver interactive simulations and host multiple events for its Galaxy System at leading bronchology and pulmonology gathering SAN...